Biophysical analysis of SARS‐CoV‐2 transmission and theranostic development via N protein computational characterization
Open Access
- 29 October 2020
- journal article
- review article
- Published by Wiley in Biotechnology Progress
- Vol. 37 (2), e3096
- https://doi.org/10.1002/btpr.3096
Abstract
Recently, SARS‐CoV‐2 has been identified as the causative factor of viral infection called COVID‐19 that belongs to the zoonotic beta coronavirus family known to cause respiratory disorders or viral pneumonia, followed by an extensive attack on organs that express angiotensin‐converting enzyme II (ACE2). Human transmission of this virus occurs via respiratory droplets from symptomatic and asymptomatic patients, which are released into the environment after sneezing or coughing. These droplets are capable of staying in the air as aerosols or surfaces and can be transmitted to persons through inhalation or contact with contaminated surfaces. Thus, there is an urgent need for advanced theranostic solutions to control the spread of COVID‐19 infection. The development of such fit‐for‐purpose technologies hinges on a proper understanding of the transmission, incubation, and structural characteristics of the virus in the external environment and within the host. Hence, this article describes the development of an intrinsic model to describe the incubation characteristics of the virus under varying environmental factors. It also discusses on the evaluation of SARS‐CoV‐2 structural nucleocapsid protein properties via computational approaches to generate high‐affinity binding probes for effective diagnosis and targeted treatment applications by specific targeting of viruses. In addition, this article provides useful insights on the transmission behavior of the virus and creates new opportunities for theranostics development.Keywords
This publication has 86 references indexed in Scilit:
- Cell death and infection: A double-edged sword for host and pathogen survivalThe Journal of cell biology, 2011
- Molecular dynamics simulations and drug discoveryBMC Biology, 2011
- Inhibition of HBV replication by theophyllineAntiviral Research, 2011
- High-Performance Drug Discovery: Computational Screening by Combining Docking and Molecular Dynamics SimulationsPLoS Computational Biology, 2009
- Protein function annotation by homology-based inferenceGenome Biology, 2009
- Structure of the SARS Coronavirus Nucleocapsid Protein RNA-binding Dimerization Domain Suggests a Mechanism for Helical Packaging of Viral RNAJournal of Molecular Biology, 2007
- Modular organization of SARS coronavirus nucleocapsid proteinJournal of Biomedical Science, 2005
- Global stability of an SEI epidemic model with general contact rateChaos, Solitons, and Fractals, 2005
- Electrostatics of nanosystems: Application to microtubules and the ribosomeProceedings of the National Academy of Sciences of the United States of America, 2001
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996